Biocon Limited

NSE: BIOCON

Healthcare Healthcare

₹409.25

-0.74%EOD · 8 Jun

Biocon Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹66,278 Cr

52W Range

₹440 / ₹331

Volume

2875K

49.5% delivery

1Y Return

+15.2%

P/E Ratio

147.3

P/B Ratio

1.9

ROE

1.1%

Debt / Equity

42.15

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Biocon Limited(this stock)	₹409.25	₹66,278 Cr	147.3	1.9	1.1%	0.12%
Divi's Laboratories LimitedDIVISLAB	₹6,521	₹1.73 L Cr	68.5	10.5	16.2%	0.45%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹4,410.4	₹1.49 L Cr	69.0	17.7	17.0%	0.86%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹8,358.5	₹1.20 L Cr	61.4	12.6	21.5%	0.24%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,087.6	₹1.09 L Cr	21.7	4.3	18.3%	0.09%
Max Healthcare Institute LimitedMAXHEALTH	₹1,007.45	₹98,049 Cr	66.2	8.8	14.3%	0.15%
Mankind Pharma LimitedMANKIND	₹2,357.4	₹97,339 Cr	50.5	6.3	12.4%	0.09%
Aurobindo Pharma LimitedAUROPHARMA	₹1,451.8	₹83,533 Cr	24.2	2.2	9.9%	0.27%
Laurus Labs LimitedLAURUSLABS	₹1,404.7	₹75,889 Cr	92.6	14.7	17.7%	0.17%

Technical Indicators

Full analysis · objective math, not advice

Returns

-0.7%

-1.8%

-2.3%

+5.8%

+6.6%

+15.2%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

24 Oversold

Trend Template

6/7strong

Moving Averages (price vs MA)

20-DMA

₹425

below

50-DMA

₹391

above

150-DMA

₹387

above

200-DMA

₹380

above

From 52W High

-7.1%

From 52W Low

+23.6%

Support (20D)

₹406

Resistance (20D)

₹440

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+0.4% CAGR

Up 8 of last 11 years

Earnings Quality

Accrual-heavy (watch)

OCF / Net Profit = -4.86x · 10/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.